Antifibrotics in rheumatoid arthritis-associated interstitial lung disease – real-world data from a nationwide cohort
This study with real-world data corroborates the usefulness of antifibrotics in stabilizing lung function, based on FVC and TLC. However, AEs were frequently reported and were the main cause for drug discontinuation.
Authors
- Francisca Guimarães (ORCID: https://orcid.org/0000-0003-4983-0833)
- Joana Abelha-Aleixo
- Carolina Mazeda (ORCID: https://orcid.org/0000-0002-9200-5022)
- Beatriz Mendes (ORCID: https://orcid.org/0000-0002-6559-9670)
- Margarida Correia
- Ana Catarina Duarte (ORCID: https://orcid.org/0000-0001-6128-2425)
- Carlos Marques Gomes
Institutions
- Hospitais da Universidade de Coimbra (PT)
- Hospital Center of Cova da Beira (PT)
- Hospital de São João (PT)
- Hospital Universitário de Santa Maria (BR)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Hospital Braga (PT)
- Hospital San Pedro (ES)
- Centro Hospitalar de Vila Nova de Gaia (PT)
- Hospital Garcia de Orta (PT)
- Hospital de Santa Maria (PT)
- Unidade Hospitalar de Bragança (PT)
Publication Details
- Journal
- ARP Rheumatology
- Published
- 2024-09-30
- DOI
- https://doi.org/10.63032/popm9413
- Citations
- 10
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 4.19